These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15981212)

  • 21. Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis.
    Dell'Aica I; Niero R; Piazza F; Cabrelle A; Sartor L; Colalto C; Brunetta E; Lorusso G; Benelli R; Albini A; Calabrese F; Agostini C; Garbisa S
    J Pharmacol Exp Ther; 2007 May; 321(2):492-500. PubMed ID: 17289834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: a possible role of hyperforin.
    Tadros MG; Mohamed MR; Youssef AM; Sabry GM; Sabry NA; Khalifa AE
    Behav Brain Res; 2009 May; 199(2):334-9. PubMed ID: 19136030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperforin.
    Beerhues L
    Phytochemistry; 2006 Oct; 67(20):2201-7. PubMed ID: 16973193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
    Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
    Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant hyperforin up-regulates VEGF in CNS tumour cells.
    Tassone E; Maran C; Masola V; Bradaschia A; Garbisa S; Onisto M
    Pharmacol Res; 2011 Jan; 63(1):37-43. PubMed ID: 20883786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells.
    Quiney C; Billard C; Mirshahi P; Fourneron JD; Kolb JP
    Leukemia; 2006 Apr; 20(4):583-9. PubMed ID: 16467866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
    Bouron A; Lorrain E
    Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways.
    Wonnemann M; Singer A; Müller WE
    Neuropsychopharmacology; 2000 Aug; 23(2):188-97. PubMed ID: 10882845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
    Buchholzer ML; Dvorak C; Chatterjee SS; Klein J
    J Pharmacol Exp Ther; 2002 May; 301(2):714-9. PubMed ID: 11961077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
    Weber CC; Kressmann S; Fricker G; Müller WE
    Pharmacopsychiatry; 2004 Nov; 37(6):292-8. PubMed ID: 15551196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperforin and its analogues inhibit CYP3A4 enzyme activity.
    Lee JY; Duke RK; Tran VH; Hook JM; Duke CC
    Phytochemistry; 2006 Dec; 67(23):2550-60. PubMed ID: 17083953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John's Wort.
    Kiewert C; Buchholzer ML; Hartmann J; Chatterjee SS; Klein J
    Neurosci Lett; 2004 Jul; 364(3):195-8. PubMed ID: 15196674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic insights into the antileukemic activity of hyperforin.
    Billard C; Merhi F; Bauvois B
    Curr Cancer Drug Targets; 2013 Jan; 13(1):1-10. PubMed ID: 22924417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent.
    Gartner M; Müller T; Simon JC; Giannis A; Sleeman JP
    Chembiochem; 2005 Jan; 6(1):171-7. PubMed ID: 15593112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.
    Hokkanen J; Tolonen A; Mattila S; Turpeinen M
    Eur J Pharm Sci; 2011 Feb; 42(3):273-84. PubMed ID: 21168483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge.
    Rodríguez-Nieto S; González-Iriarte M; Carmona R; Muñoz-Chápuli R; Medina MA; Quesada AR
    FASEB J; 2002 Feb; 16(2):261-3. PubMed ID: 11772945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular neurobiology of hyperforin.
    Bouron A
    Phytother Res; 2024 Feb; 38(2):636-645. PubMed ID: 37963759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of hyperforin analogues for inhibition of 5-lipoxygenase.
    Feisst C; Albert D; Verotta L; Werz O
    Med Chem; 2005 May; 1(3):287-91. PubMed ID: 16787324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo.
    Feisst C; Pergola C; Rakonjac M; Rossi A; Koeberle A; Dodt G; Hoffmann M; Hoernig C; Fischer L; Steinhilber D; Franke L; Schneider G; Rådmark O; Sautebin L; Werz O
    Cell Mol Life Sci; 2009 Aug; 66(16):2759-71. PubMed ID: 19579006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.